- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05303571
Project Bidof - Monovision by Pairing Bifocal and EDOF Lens (Bidof)
March 5, 2024 updated by: Matthias Bolz, Johannes Kepler University of Linz
Project Bidof - Achieving Hybrid Monovision by Pairing Bifocal and EDOF Lens Technology
Modern day cataract surgery isn't just a rehabilitative procedure anymore but rather aims at improving a patient's quality of life by reducing the need for spectacles in everyday life to a minimum.
One way of achieving this goal is by using different lens technologies, such as a mono- or bifocal lens paired a lens with EDOF technology, as EDOF lenses provide an enhanced depth of focus by creating a single elongated focal point.
As this method is well established, the aim of this study is to compare the monofocal/EDOF cohort to the bifocal/EDOF cohort and evaluate visual acuity and patient satisfaction for both combinations.
Study Overview
Status
Withdrawn
Conditions
Study Type
Observational
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Upper Austria
-
Linz, Upper Austria, Austria, 4020
- Johannes Kepler University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 99 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patient between 21 and 99 years after cataract surgery
Description
Inclusion Criteria:
- Age between 21 and 99 years
- signed informed consent form
- condition after cataract surgery
Exclusion Criteria:
- no signed informed consent form
- laser treatment of the Cornea
- macular pathologies
- corneal pathologies
- irregular astigmatism
- pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
Monodof
monofocal and EDOF lens
|
|
Bidof
Bifocal and EDOF lens
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Distance Visual Acuity
Time Frame: 6 months
|
percentage of patients with binocular distance corrected visual acuity of logMAR > 0.2
|
6 months
|
|
Intermediate Visual Acuity
Time Frame: 6 months
|
percentage of patients with binocular intermediate distance corrected visual acuity of logMAR > 0.2
|
6 months
|
|
Near Visual Acuity
Time Frame: 6 months
|
percentage of patients with binocular near visual acuity logmar < 0.2
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
contrast vision
Time Frame: 3 months
|
contrast sensitivity vision
|
3 months
|
|
Halo and Glare
Time Frame: 3 months
|
Halo and Glare Simulator
|
3 months
|
|
Defocus curve
Time Frame: 3 and 6 months
|
Defocus curve
|
3 and 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 14, 2022
Primary Completion (Actual)
March 14, 2023
Study Completion (Actual)
March 14, 2023
Study Registration Dates
First Submitted
March 22, 2022
First Submitted That Met QC Criteria
March 22, 2022
First Posted (Actual)
March 31, 2022
Study Record Updates
Last Update Posted (Actual)
March 7, 2024
Last Update Submitted That Met QC Criteria
March 5, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KUK-Ophthalmology-005
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataract Senile
-
Carl Zeiss Meditec AGCompleted
-
Carl Zeiss Meditec AGRecruitingCataract SenileSpain, Bulgaria, Czechia, Romania
-
Vienna Institute for Research in Ocular SurgeryRecruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityBeijing Tongren Hospital; Eye & ENT Hospital of Fudan University; The First Affiliated... and other collaboratorsEnrolling by invitation
-
Taipei Nobel Eye ClinicCompletedCataract SenileTaiwan
-
Wendell ScottJohnson & Johnson Surgical Vision, Inc.CompletedCataract SenileUnited States
-
Carl Zeiss Meditec AGCompletedCataract SenileRomania
-
Carl Zeiss Meditec AGCompleted
-
Johannes Kepler University of LinzCompleted
-
Vienna Institute for Research in Ocular SurgeryCompleted